Overview

Study To Evaluate Safety And Tolerability Of Pegaptanib Sodium In Patients With Diabetic Macular Edema

Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
This study will asses sthe safety of pegaptanib sodium in patients with diabetic macular edema. The hypothesis is that pegaptanib is safe and efficacious in patients with diabetic macular edema.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer